INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer | 最新消息 - 中國醫藥大學附設醫院

:::

院外單位健康通報

實名登記系統

"> 回首頁LOGO按鈕

繁簡 EN

最新消息

News & Message

:::

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

最新消息

2026/2/3

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

回上頁

相關文章

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

側邊開關圖示

中國醫點通

百度搜狗 360搜索 “70后”克衣色尔·克尤木任新疆维吾尔自治区副主席加强中欧经贸合作、应对美加征关税，这场会谈释放重要信号靠“贵妇养生”年入7亿，高管嫌挣钱少先“跑了”？春来定风波贵媳大乱斗山西发布大风黄色预警

<code id='9259b'></code><style id='13a59'></style>

<acronym id='cab5e'></acronym>

<center id='127d2'><center id='d544c'><tfoot id='6aecf'></tfoot></center><abbr id='ad7d8'><dir id='b05dc'><tfoot id='78779'></tfoot><noframes id='75b27'>

<optgroup id='df47b'><strike id='b77fd'><sup id='505bc'></sup></strike><code id='5366e'></code></optgroup>

<b id='89372'><label id='64452'><select id='65edd'><dt id='03148'><span id='d01ca'></span></dt></select></label></b><u id='54a10'></u>

~~<i id='8c845'><strike id='04861'><tt id='3dad4'><pre id='719d0'></pre></tt></strike></i>~~